Block-LC: A Phase 2 Randomized, Single-blind, Sham-controlled Trial to Evaluate the Quality of Life and Symptom Severity After Stellate Ganglion Block Procedure in Persons 18-65 Years With Long COVID, Followed by a Sham-to-active Open Label Extension | Arctuva